1. Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases. (8th August 2020) Authors: Fowler, Alan J; Hebron, Michaeline; Balaraman, Kaluvu; Shi, Wangke; Missner, Alexander A; Greenzaid, Jonathan D; Chiu, Timothy L; Ullman, Clementina; Weatherdon, Ethan; Duka, Val; Torres-Yaghi, Yasar; Pagan, Fernando L; Liu, Xiaoguang; Ressom, Habtom; Ahn, Jaeil; Wolf, Christian; Moussa, Charbel Journal: Human molecular genetics Issue: Volume 29:Number 17(2020) Page Start: 2882 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DT‐02‐06: A NOVEL SMALL MOLECULE INHIBITOR OF THE DISCOIDIN DOMAIN RECEPTORS (DDR) REDUCES TAU AND AMYLOID‐β AND IMPROVES COGNITION IN MODELS OF ALZHEIMER'S DISEASE. (1st July 2019) Authors: Fowler, Alan J.; Hebron, Michaeline; Shi, Wangke; Missner, Alexander A.; Hassan, Diandra; Lynch, Ciaran; Kavulu, Balaraman; Liu, Xiaoguang; Wolf, Christian; E-H Moussa, Charbel Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7(2019)Part 29 Page Start: P1491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Erratum to: Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases. Issue 13 (24th May 2021) Authors: Fowler, Alan J; Hebron, Michaeline; Balaraman, Kaluvu; Shi, Wangke; Missner, Alexander A; Greenzaid, Jonathan D; Chiu, Timothy L; Ullman, Clementina; Weatherdon, Ethan; Duka, Val; Torres-Yaghi, Yasar; Pagan, Fernando L; Liu, Xiaoguang; Ressom, Habtom; Ahn, Jaeil; Wolf, Christian; Moussa, Charbel Journal: Human molecular genetics Issue: Volume 30:Issue 13(2021) Page Start: 1271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Nilotinib Effects on Safety, Tolerability, and Biomarkers in Alzheimer's Disease. Issue 1 (28th May 2020) Authors: Turner, Raymond S.; Hebron, Michaeline L.; Lawler, Abigail; Mundel, Elizabeth E.; Yusuf, Nadia; Starr, J. Nathan; Anjum, Muhammad; Pagan, Fernando; Torres‐Yaghi, Yasar; Shi, Wangke; Mulki, Sanjana; Ferrante, Dalila; Matar, Sara; Liu, Xiaoguang; Esposito, Giuseppe; Berkowitz, Frank; Jiang, Xiong; ... Journal: Annals of neurology Issue: Volume 88:Issue 1(2020) Page Start: 183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Nilotinib effects on safety, tolerability, and biomarkers in Alzheimer's disease: A phase 2, double‐blind, randomized, placebo‐controlled trial: Human/Human trials: Anti‐amyloid. (7th December 2020) Authors: Turner, Raymond Scott; Hebron, Michaeline; Lawler, Abigail; Mundel, Elizabeth; Yusuf, Nadia; Starr, Nathan; Pagan, Fernando; Torres‐Yaghi, Yasar; Shi, Wangke; Mulki, Sanjana; Ferrante, Dalila; Matar, Sara; Liu, Xiaoguang; Esposito, Guiseppe; Berkowitz, Frank; Jiang, Xiong; Ahn, Jaeil; Moussa, Cha... Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ubiquitin specific protease-13 independently regulates parkin ubiquitination and alpha-synuclein clearance in alpha-synucleinopathies. (16th October 2018) Authors: Liu, Xiaoguang; Hebron, Michaeline; Shi, Wangke; Lonskaya, Irina; Moussa, Charbel E-H Journal: Human molecular genetics Issue: Volume 28:Number 4(2019) Page Start: 548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗